This country profile provides an overview of Chad’s progress in reaching those in need of mass NTD treatment based on 2017 data.

*This includes all countries in Africa that are endemic for at least one of the five NTDs

Download country profiles

Treatment coverage

Elephantiasis
NR
Blinding trachoma
92%
Intestinal worms
29%
Bilharzia
NR
River blindness
NR
4.45 million people received treatment in Chad in 2017 0.4 million people did not receive treatment in Chad in 2017

Priorities for progress in Chad

  • As a priority, Chad should submit the data on preventive chemotherapy (PC) coverage for bilharzia, river blindness and elephantiasis.
  • Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.

Elephantiasis

Treatment coverage was 51% in 2016 and not reported in 2017.

People needing treatment
3.18m
People receiving treatment
Not reported

Blinding trachoma

Treatment coverage increased from 38% in 2016 to 92% in 2017.

People needing treatment
4.85m
People receiving treatment
4.45m

Intestinal worms

Treatment coverage increased from 6% in 2016 to 29% in 2017.

Pre-sch and school-aged children needing treatment
0.38m
Pre-school and school-aged children receiving treatment
0.11m

Bilharzia

Treatment coverage was not reported in 2016 or 2017.

School-aged children needing treatment
2.14m
School-aged children receiving treatment
Not reported

River blindness

Treatment coverage was 68% in 2016 and not reported in 2017.

People needing treatment
3.82m
People receiving treatment
Not reported

The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Chad.